LABATE, Angelo
 Distribuzione geografica
Continente #
EU - Europa 3.660
NA - Nord America 2.568
AS - Asia 2.201
SA - Sud America 773
AF - Africa 67
OC - Oceania 9
Totale 9.278
Nazione #
US - Stati Uniti d'America 2.470
RU - Federazione Russa 2.203
SG - Singapore 947
BR - Brasile 640
IE - Irlanda 517
HK - Hong Kong 411
CN - Cina 348
IT - Italia 301
SE - Svezia 250
VN - Vietnam 162
DE - Germania 82
BD - Bangladesh 60
FR - Francia 59
IN - India 55
GB - Regno Unito 51
AR - Argentina 49
AT - Austria 42
MX - Messico 41
CA - Canada 33
TR - Turchia 26
FI - Finlandia 24
IQ - Iraq 24
PK - Pakistan 22
EC - Ecuador 21
NL - Olanda 21
PL - Polonia 21
ID - Indonesia 20
CO - Colombia 19
JP - Giappone 18
ZA - Sudafrica 18
UA - Ucraina 16
DZ - Algeria 15
DK - Danimarca 13
ES - Italia 13
UZ - Uzbekistan 12
IL - Israele 11
MA - Marocco 11
VE - Venezuela 10
MY - Malesia 9
PY - Paraguay 9
TN - Tunisia 9
CL - Cile 8
CZ - Repubblica Ceca 7
KZ - Kazakistan 7
AZ - Azerbaigian 6
BG - Bulgaria 6
BO - Bolivia 6
KG - Kirghizistan 6
LV - Lettonia 6
PE - Perù 6
AM - Armenia 5
AU - Australia 5
JO - Giordania 5
LT - Lituania 5
PA - Panama 5
PH - Filippine 5
SY - Repubblica araba siriana 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
BY - Bielorussia 4
HN - Honduras 4
IR - Iran 4
JM - Giamaica 4
KE - Kenya 4
NI - Nicaragua 4
NZ - Nuova Zelanda 4
OM - Oman 4
RS - Serbia 4
TW - Taiwan 4
CR - Costa Rica 3
EG - Egitto 3
PS - Palestinian Territory 3
SA - Arabia Saudita 3
AL - Albania 2
BE - Belgio 2
CI - Costa d'Avorio 2
CY - Cipro 2
GR - Grecia 2
GT - Guatemala 2
KR - Corea 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
NO - Norvegia 2
TH - Thailandia 2
BF - Burkina Faso 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CG - Congo 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
HR - Croazia 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
MK - Macedonia 1
NG - Nigeria 1
NP - Nepal 1
PR - Porto Rico 1
PT - Portogallo 1
Totale 9.275
Città #
Moscow 683
Dublin 517
Hong Kong 409
Ashburn 406
Singapore 379
Nyköping 230
San Jose 198
Dallas 186
Princeton 184
Medford 165
Chandler 136
The Dalles 105
Messina 104
Los Angeles 88
Beijing 87
São Paulo 63
Ho Chi Minh City 48
New York 45
Santa Clara 38
Hanoi 37
Nuremberg 36
Munich 31
Vienna 24
Tianjin 23
Buffalo 22
Redondo Beach 21
Lauterbourg 19
Orem 19
Bari 18
Milan 18
Tokyo 18
Brasília 17
Rio de Janeiro 17
Shanghai 17
Chennai 16
Mexico City 15
Warsaw 15
Denver 14
Guangzhou 14
Houston 14
Phoenix 14
Poplar 14
Brooklyn 13
Council Bluffs 13
Palermo 13
Shenzhen 13
Belo Horizonte 12
Chicago 12
Amsterdam 11
Seattle 11
Stockholm 11
Boston 10
Catania 10
Tashkent 10
Atlanta 9
Brøndby 9
Dhaka 9
Frankfurt am Main 9
Johannesburg 9
Lappeenranta 9
Porto Alegre 9
Rome 9
Settimo Torinese 9
Toronto 9
Turku 9
Florence 8
Guarulhos 8
Haiphong 8
Montreal 8
Mumbai 8
Querétaro 8
Salvador 8
San Francisco 8
Asunción 7
Guayaquil 7
London 7
Ankara 6
Bishkek 6
Campinas 6
Da Nang 6
Karachi 6
Manchester 6
Miami 6
Prague 6
Riga 6
Sorocaba 6
Baghdad 5
Bagheria 5
Baku 5
Bogotá 5
Casablanca 5
Catanzaro 5
Cellamare 5
Hyderabad 5
Hải Dương 5
Jacksonville 5
Jakarta 5
Joinville 5
Kuala Lumpur 5
Lahore 5
Totale 4.977
Nome #
CPAP therapy improved sleep and reduced seizures in a young, obese epileptic woman with OSA 189
The real-world effectiveness of intravenous brivaracetam as a second-line treatment in status epilepticus 147
Brivaracetam as add-on treatment in patients with post-stroke epilepsy: real-world data from the BRIVAracetam add-on First Italian netwoRk Study (BRIVAFIRST) 145
A case of frontal lobe seizures with ‘dancing-like’ semiology 145
A retrospective multicentric study on the effectiveness of intravenous brivaracetam in seizure clusters: Data from the Italian experience 132
Management of status epilepticus in patients with liver or kidney disease: a narrative review 125
Genetics of reflex seizures and epilepsies in humans and animals 123
A systems-level analysis highlights microglial activation as a modifying factor in common epilepsies 115
A possible case of natalizumab-dependent suicide attempt: A brief review about drugs and suicide 114
AMPA receptors and perampanel behind selected epilepsies: current evidence and future perspectives 112
Human expressive movements: The boundary between health and disease from a contaminated perspective 110
A Functional Genetic Variation of the 5-HTR2A Receptor Affects Age at Onset in Patients with Temporal Lobe Epilepsy 110
Hypertension, seizures, and epilepsy: a review on pathophysiology and management 108
SLEEP HYPERMOTOR EPILEPSY VS NREM PARASOMNIAS: A CHALLENGING CASE REPORT 106
MR-Guided Focused Ultrasound for Refractory Epilepsy: Where Are We Now? 105
Epilepsy Study Group of the Italian Neurological Society. Late epileptic seizures following cerebral venous thrombosis: a systematic review and meta-analysis. 105
Advanced MRI Morphologic Study Shows No Atrophy in Healthy Individuals with Hippocampal Hyperintensity 104
Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset seizures 104
Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk STudy (BRIVAFIRST) 101
Advanced morphological neuroimaging study in lateral temporal lobe epilepsy: A multicentric study 100
White matter abnormalities across different epilepsy syndromes in adults: an ENIGMA-Epilepsy study 98
A novel mutation in the notch3 gene in an Italian family with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: genetic and MRI spectroscopic analyses 97
3-T magnetic resonance imaging simultaneous automated multimodal approach improves detection of ambiguous visual hippocampal sclerosis 96
Insight into epileptic and physiological déjà vu: from a multicentric cohort study 96
Correction to: Adjunctive Brivaracetam in Focal Epilepsy: Real‑World Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST) (CNS Drugs, (2021), 35, 12, (1289-1301), 10.1007/s40263-021-00856-3) 96
Epilepsy associated with Leukoaraiosis mainly affects temporal lobe: a casual or causal relationship? 95
A functional polymorphism in the SCN1A gene does not influence antiepileptic drug responsiveness in Italian patients with focal epilepsy 95
Adolescents with Neuropsychiatric Disorders during the COVID-19 Pandemic: Focus on Emotional Well-Being and Parental Stress. 93
Binaural Beats Reduce Postoperative Morphine Consumption in Older adults After Total Knee Replacement Surgery 91
Levetiracetam vs Lamotrigine as First-Line Antiseizure Medication in Female Patients With Idiopathic Generalized Epilepsy 91
A novel de novo HCN1 loss-of-function mutation in genetic generalized epilepsy causing increased neuronal excitability 91
Diagnostic Biomarkers of Epilepsy 89
A familial t(4;8) translocation segregates with epilepsy and migraine with aura 88
Detection of hippocampal atrophy in patients with temporal lobe epilepsy: a 3-Tesla MRI shape 87
Failure to confirm association of a polymorphism in KCNMB4 gene with mesial temporal lobe epilepsy 86
A Loss-of-Function HCN4 Mutation Associated With Familial Benign Myoclonic Epilepsy in Infancy Causes Increased Neuronal Excitability 86
Acute bulbar palsy without ophtalmoplegia associated with anti-GD3 IgM antibodies 86
Epilepsy beyond seizures: embracing a holistic perspective. Proceedings of the 2nd meeting (Episicily) of the epilepsy study group of the Italian Society of neurology 86
Spectrum of epilepsy with eyelid myoclonia: Delineation of disease subtypes from a large multicenter study 85
Pharmacovigilance and drug safety 2011 in Calabria (Italy): Adverse events analysis 85
Perampanel as first add-on choice on the treatment of mesial temporal lobe epilepsy: an observational real-life study 85
Lacosamide in patients with temporal lobe epilepsy: An observational multicentric open-label study 85
Deep Learning Representation from Electroencephalography of Early-Stage Creutzfeldt-Jakob Disease and Features for Differentiation from Rapidly Progressive Dementia 83
Brand-to-generic levetiracetam switching: a 4-year prospective observational real-life study 82
A brainstem hypermetabolism in a patient with essential palatal tremor: A simultaneous 18F-FDG-PET/3 T-MRI study 81
Epilepsy and sleep disorders improve in adolescents and adults with Angelman syndrome: A multicenter study on 46 patients 81
Late drug-resistance in mild MTLE: Can it be influenced by preexisting white matter alterations? 81
Sex-based electroclinical differences and prognostic factors in epilepsy with eyelid myoclonia 80
Autosomal dominant lateral temporal epilepsy (ADLTE): absence of chromosomal rearrangements in LGI1 gene 80
Lamotrigine positively affects the development of psychiatric comorbidity in epileptic animals, while psychiatric comorbidity aggravates seizures 80
Myoclonus: Differential diagnosis and current management 79
A novel mutation in the Notch3 gene in an Italian family with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: genetic and magnetic resonance spectroscopic findings 79
Profile of brivaracetam and its potential in the treatment of epilepsy 79
A puzzling case without solution: isolated late-onset epileptic seizure 78
Corticobulbar activity in healthy humans and Parkinson’s disease: a study protocol for a novel biomarker of motivational arousal 77
Epilepsy and Immune System: A Tour Around the Current Literature 76
The ENIGMA-Epilepsy working group: Mapping disease from large data sets 73
Topographic divergence of atypical cortical asymmetry and atrophy patterns in temporal lobe epilepsy 72
Family history and frontal lobe seizures predict long-term remission in newly diagnosed cryptogenic focal epilepsy 72
Psychiatric and Behavioural Side Effects Associated With Perampanel in Patients With Temporal Lobe Epilepsy. A Real-World Experience 71
Event-based modeling in temporal lobe epilepsy demonstrates progressive atrophy from cross-sectional data 71
Progressive myoclonus epilepsies—Residual unsolved cases have marked genetic heterogeneity including dolichol-dependent protein glycosylation pathway genes 71
Structural network alterations in focal and generalized epilepsy follow axes of epilepsy risk gene expression: an enigma study. 69
Looking for indicative magnetic resonance imaging signs of hippocampal developmental abnormalities in patients with mesial temporal lobe epilepsy and healthy controls 69
Network-based atrophy modeling in the common epilepsies: A worldwide ENIGMA study 69
Efficacy and safety of branded vs generic lacosamide in epilepsy: a retrospective real-world study 68
Generalized versus partial reflex seizures: a review. 67
Interpretable surface-based detection of focal cortical dysplasias: a MELD study. 67
Circulating microRNAs as Potential Novel Diagnostic Biomarkers to predict Drug Resistance in Temporal Lobe Epilepsy: a Pilot Study 66
Enlarging the clinical spectrum of chorea-acanthocytosis 65
Exercise-induced rhabdomyolysis as unusual manifestation of GLUT-1 Deficiency Syndrome 65
Pharmacodynamic potentiation of antiepileptic drugs' effects by some HMG-CoA reductase inhibitors against audiogenic seizures in DBA/2 mice 65
Genome-wide identification and phenotypic characterization of seizure-associated copy number variations in 741,075 individuals 52
GWAS meta-analysis of over 29,000 people with epilepsy identifies 26 risk loci and subtype-specific genetic architecture 52
Utility of raw electroencephalography monitoring for estimating level of sedation in the perioperative setting 50
The broad-spectrum activity of perampanel: state of the art and future perspective of AMPA antagonism beyond epilepsy 50
Relationship between genetic variant in pre-microRNA-146a and genetic predisposition to temporal lobe epilepsy: A case-control study 46
Validation Study of Italian Version of Inventory for Déjà Vu Experiences Assessment (I-IDEA): A Screening Tool to Detect Déjà Vu Phenomenon in Italian Healthy Individuals 45
The efficacy of switching intravenous to oral brivaracetam following status epilepticus: A real-world, multicenter Sicilian study 44
The mystery of unexplained traumatic sudden falls. A clinical case that adds a new feasible cause 44
The efficacy of perampanel as adjunctive therapy in drug-resistant focal epilepsy in a “real world” context: focus on temporal lobe epilepsy 43
Atlas of lesion locations and postsurgical seizure freedom in focal cortical dysplasia: A MELD study 42
Psychiatric Assessment in Patients with Mild Temporal Lobe Epilepsy 41
Juvenile Huntington's disease presenting as progressive myoclonic epilepsy 40
Benign mesial temporal lobe epilepsy 39
Anti-N-methyl-D-aspartate-glutamic-receptor encephalitis presenting as paroxysmal exercise-induced foot weakness 39
Kufs disease due to mutation of CLN6: clinical, pathological and molecular genetic features 38
Sleep effects in drug-resistant epileptic patients taking perampanel: an observational study 37
Usefulness of rectal biopsy for the diagnosis of Kufs disease: a controlled study and review of the literature 37
Mutations in PRRT2 result in familial infantile seizures with heterogeneous phenotypes including febrile convulsions and probable SUDEP 37
Typical childhood absence seizures are associated with thalamic activation 37
Positivity to p-ANCA in patients with status epilepticus 37
Artificial intelligence for classification of temporal lobe epilepsy with ROI-level MRI data: A worldwide ENIGMA-Epilepsy study 36
Amygdala dysplasia with temporal lobe epilepsy and obsessive-compulsive disorder: An fMRI/EEG study 35
Predictive factors of Status Epilepticus and its recurrence in patients with adult–onset seizures: A multicenter, long follow–up cohort study 35
ApoE epsilon4 allele and disease duration affect verbal learning in mild temporal lobe epilepsy 35
Determinants of health-related quality of life in pharmacoresistant epilepsy: Results from a large multicenter study of consecutively enrolled patients using validated quantitative assessments 34
Temporal lobe epilepsy as a unique manifestation of multiple sclerosis 34
Babylonian knowledge about temporal lobe epilepsy: distinguishing mesial from lateral forms 34
Antiepileptic drugs and intrauterine death: A prospective observational study from EURAP 33
Totale 7.729
Categoria #
all - tutte 33.830
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.830


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022364 0 1 0 3 0 0 1 1 2 5 2 349
2022/20231.145 193 103 54 7 12 65 51 21 604 4 29 2
2023/2024333 17 46 35 112 18 20 4 4 0 45 8 24
2024/20251.973 30 31 102 46 148 109 128 164 427 207 207 374
2025/20265.566 303 310 356 471 498 1.143 676 636 629 361 177 6
Totale 9.402